AHR closes $572M Kensington deal, testing NFFO guidance
- American Healthcare REIT closed six Kensington communities for $572 million
- Two remaining communities expected to close in Q4, completing $873M deal
- Forward equity offering covers 15.2375 million shares, pending physical settlement
- Current 2026 NFFO guidance of $2.17 midpoint excludes Kensington impact
- Pre-deal payout ratio stands at 46.1% based on Q2 distribution

*this image is generated using AI for illustrative purposes only.
American Healthcare REIT Inc (NYSE: AHR) has closed six of the eight senior housing communities in its $873 million Kensington Senior Living portfolio. The initial closings total approximately $572 million, moving most of the transaction from pending to completed status.
The six properties comprise 464 units. Two more communities remain under definitive agreements and are expected to close in the fourth quarter, subject to specified conditions. The full portfolio totals 745 units.
Financing Structure and Share Count
AHR entered a large forward equity offering on Aug. 10, the same date it signed the Kensington acquisition agreements. The offering covered 13.25 million shares, and the underwriters later exercised their option for another 1.9875 million shares. That brings the offering-linked total to 15.2375 million shares.
These shares should not be treated as newly issued AHR shares today. Forward sellers borrowed and sold those shares into the market to hedge their obligations. AHR did not receive proceeds from those borrowed-share sales. The company intends, subject to alternative settlement rights, to physically settle by delivering shares to the forward purchasers in exchange for cash based on the applicable forward price. Settlement can occur on dates selected by AHR no later than Aug. 10, 2028.
| Metric | Value |
|---|---|
| Total Portfolio Price | $873 million |
| Initial Closings | $572 million |
| Units Closed | 464 |
| Total Units | 745 |
| Forward Shares | 15.2375 million |
Impact on NFFO Guidance
AHR’s current 2026 NFFO guidance predates the Kensington deal. The company raised guidance on Aug. 6 to $2.15 to $2.19 per diluted share, with a $2.17 midpoint. This guidance assumed no additional transactions or capital-markets activity beyond activity already disclosed as completed. Kensington was announced four days later.
The next per-share question is whether the earnings added by the portfolio absorb the common-share denominator created as the forward sales settle. AHR’s second-quarter common distribution was $0.25 per share, equal to $1.00 annualized. Against the $2.17 midpoint of 2026 NFFO guidance, that equals a 46.1% payout by DFB calculation.
That payout is a pre-Kensington reference point. It should not be read as the post-acquisition payout ratio because the Aug. 6 guidance excluded transaction and capital-markets activity that had not been completed at that time.
What the Numbers Show
The acquisition adds operating assets while physical settlement of the forward agreements can add common shares. Those changes move different sides of the per-share equation. The $873 million purchase price shows the scale of the portfolio. The forward agreements show how the common-share denominator can expand. The next post-deal NFFO-per-share update will show how much of that additional denominator the acquired earnings absorb.
The portfolio is concentrated in higher-acuity senior housing. About 93% of its beds were dedicated to assisted living and memory care as of June 30, according to the August prospectus. AHR also said it believes the portfolio will enhance its NFFO growth potential in year one. That is a management expectation, not a reported post-acquisition per-share result.
How will the physical settlement of the 15.24 million forward shares impact AHR's diluted NFFO per share relative to the current $2.17 midpoint guidance?
What specific financing instruments or debt structures are being utilized to fund the remaining $301 million of the Kensington acquisition pending Q4 closing?
Given the portfolio's 93% concentration in assisted living and memory care, how does AHR plan to mitigate regulatory and staffing risks associated with higher-acuity senior housing?

































